Compounds > n,n-dimethylarginine
Page last updated: 2024-09-03

n,n-dimethylarginine and enalapril

n,n-dimethylarginine has been researched along with enalapril in 4 studies

Compound Research Comparison

Studies
(n,n-dimethylarginine)		Trials
(n,n-dimethylarginine)		Recent Studies (post-2010)
(n,n-dimethylarginine)		Studies
(enalapril)		Trials
(enalapril)		Recent Studies (post-2010) (enalapril)
2,2162281,2216,3111,924859

Protein Interaction Comparison

ProteinTaxonomyn,n-dimethylarginine (IC50)enalapril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.3536
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)2.7083
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)1.2
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.14
Angiotensin-converting enzyme 2 Homo sapiens (human)0.14

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delles, C; Gekle, M; John, S; Schmieder, RE; Schneider, MP1
Chang, MS; Chen, JW; Hsu, NW; Lin, SJ; Wu, TC1
Condorelli, M; de Nigris, F; Ignarro, LJ; Liguori, A; Napoli, C; Pignalosa, O; Sica, V1
Chen, BM; Tao, LJ; Xiong, Y; Zhang, WR1

Trials

4 trial(s) available for n,n-dimethylarginine and enalapril

ArticleYear
Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension.
    American journal of hypertension, 2002, Volume: 15, Issue:7 Pt 1

    Topics: Acrylates; Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Humans; Hypertension; Imidazoles; Male; Receptor, Angiotensin, Type 1; Thiophenes

2002
Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    The American journal of cardiology, 2002, Nov-01, Volume: 90, Issue:9

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biological Availability; Coronary Circulation; Double-Blind Method; Enalapril; Endothelium, Vascular; Exercise Test; Female; Hemodynamics; Humans; Male; Microcirculation; Microvascular Angina; Middle Aged; Nitric Oxide; Statistics as Topic; Time; Treatment Outcome; von Willebrand Factor

2002
Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    American heart journal, 2004, Volume: 148, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Arginine; Captopril; Enalapril; Female; Humans; Hypertension; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress

2004
[Changes of serum asymmetric dimethylarginine in essential hypertension before and after the treatment].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2005, Volume: 30, Issue:1

    Topics: Adult; Aged; Antihypertensive Agents; Arginine; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase

2005